Clinical Trial Update: A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of topical roflumilast 0.3% foam for hidradenitis suppurativa, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• roflumilast topical foam 0.3% (roflumilast)

Snippet

Sponsor: Tulane University | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: RECRUITING